Ruth Gabriela Herrera-Gómez

3PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 24, 2022
Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease.

Ruth Gabriela Herrera-Gómez, Miruna Grecea, Claire Gallois

|Mar 25, 2020
Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4.

Romain-David Seban, Antoine Moya-Plana, Lara Antonios

Pageof 1